AzTrials
AzTrials

Intra-Abdominal HypertensionNCT05732545

Application of Enteral Nutrition Program in Patients With Intra-abdominal Hypertension Oriented by Intra-abdominal Pressure

A study testing enteral nutrition program for patients with abdominal hypertension guided by abdominal pressure in people with Intra-Abdominal Hypertension, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, relevant contents of the enteral nutrition nursing programs for severe patients with abdominal pressure were systematically searched, and quality evaluation was carried out based on existing evidence. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intra-Abdominal Hypertension
What is being tested?
enteral nutrition program for patients with abdominal hypertension guided by abdominal pressure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
218 participants
Where
1 siteChina
Study dates
1 Jan 2022to 1 Nov 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult
  1. Inclusion Criteria
  2. 12mmHg≤ intraperitoneal pressure ≤20mmHg (1mmHg=0.133kPa)
  3. ≥18 years of age
  4. Consistent with the indications of early enteral nutrition
  • Patients with nutritional risk, gastrointestinal function, or partial gastrointestinal function and unable to eat through the mouth
  • Stable hemodynamics (MAP > 65mmHg, blood lactic acid < 4mmol/L, and vasoactive drugs in the process of reduction or withdrawal)
  1. Patients or their family members sign the informed consent
  2. Exclusion Criteria
  3. Pregnant or lactating female patients
  4. Patients with recent abdominal surgery
  5. Patients with a large number of abdominal effusions;
  6. There are contraindications to enteral nutrition
  • Uncontrolled shock
  • Uncontrolled hypoxemia and acidosis
  • Uncontrolled upper gastrointestinal bleeding
  • GRV > 500mL/ 6h
  • Intestinal ischemia
  • Intestinal obstruction
  • Abdominal space syndrome (ACS)
  • High fistula without distal feeding

Trial locations and contacts

1 site in 1 country.

China1 site
  • Feng Xiuqin

    Hangzhou, 310000

Other trials in China

About this study

In this study, relevant contents of the enteral nutrition nursing programs for severe patients with abdominal pressure were systematically searched, and quality evaluation was carried out based on existing evidence. Based on evidence-based evidence, an enteral nutrition nursing program for patients with abdominal pressure was constructed, to improve the feed tolerance of patients with abdominal pressure, increase nutritional compliance rate, and improve patient prognosis.

Read the detailed description

Background: Enteral nutrition is the preferred method of artificial nutrition for critically ill patients. Early enteral nutrition within 24 to 48 hours after admission can maintain intestinal mucosal barrier function, increase local blood flow, reduce bacterial migration, and reduce the incidence of intestinal infections. Increased abdominal pressure is considered to be an independent risk factor for feeding intolerance in severe patients. Patients with abdominal pressure are prone to complications such as diarrhea, abdominal distension, vomiting, and even aspiration, which forces the suspension or suspension of enteral nutrition and leads to insufficient nutritional intake in patients. At present, there is evidence that regulating enteral nutrition through monitoring intra-abdominal pressure can effectively reduce the incidence of feeding intolerance in patients. Domestic and foreign scholars have formulated nutrition management programs for patients with intra-abdominal pressure from different aspects, such as monitoring and grading of intra-abdominal pressure, evaluation and management of tolerance, and prevention of complications. However, The standardized enteral nutrition feeding program oriented by the monitoring of intra-abdominal pressure has not yet formed a unified standard.

Objective: This study conducted a quality evaluation based on existing evidence, adopted evidence-based research methods to establish an enteral nutrition program for patients with abdominal hypertension oriented by abdominal pressure, and aimed to improve the feeding tolerance of patients with abdominal hypertension, improve the nutritional compliance rate and improve the prognosis of patients through the implementation of evidence-based practice programs.

Being tested
enteral nutrition program for patients with abdominal hypertension guided by abdominal pressure
Keywords
Intra-Abdominal Hypertention, Enteral Nutrition, Feeding Intolerance
Medical subject headings
Intra-Abdominal Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • enteral nutrition program for patients with abdominal hypertension guided by abdominal pressureBehavioural

    There are 4 aspects of intra-abdominal pressure monitoring, source control and treatment for the etiology of increased abdominal pressure, enteral nutrition program, enteral nutrition tolerance evaluation and treatment

Study groups in NCT05732545
Study groupRoleWhat they receive
enteral nutrition program by intra-abdominal pressureExperimentalenteral nutrition program for patients with intra-abdominal hypertension guided by intra-abdominal pressure
Receives: Behavioral: enteral nutrition program for patients with abdominal hypertension guided by abdominal pressure
Routine nursing measuresNo interventionRoutine nursing measures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of feeding intolerance

    Incidence of feeding intolerance: refers to the frequency of new cases of feeding intolerance within 7 days after the initiation of enteral nutrition.

    Measured: 7 days

Secondary outcomes (1)
  1. The standard rate of feeding

    Enteral nutrition feeding standard rate (%)=(actual feeding quantity ÷ target feeding quantity)×100%

    Measured: 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2023
  2. Study start1 Jan 2022
  3. Primary completion1 Oct 2022
  4. Study completion1 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Sequential
Masking
Single blind
Who is masked
Participant
Enrolment
218 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05732545
Sponsor's protocol ID
2021-0899
Status last verified
Feb 2023
First submitted
8 Feb 2023
Last updated
23 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing enteral nutrition program for patients with abdominal hypertension guided by abdominal pressure in people with Intra-Abdominal Hypertension, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of feeding intolerance (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in